Peel Hunt reaffirmed their add rating on shares of Udg Healthcare PLC (LON:UDG) in a research report sent to investors on Thursday morning. Peel Hunt currently has a GBX 830 ($10.95) price objective on the stock.

A number of other research analysts also recently commented on the company. Liberum Capital reissued a buy rating and issued a GBX 760 ($10.03) price target on shares of Udg Healthcare PLC in a report on Tuesday, April 11th. Berenberg Bank increased their price target on Udg Healthcare PLC from GBX 745 ($9.83) to GBX 800 ($10.55) and gave the company a hold rating in a report on Friday, June 23rd. Jefferies Group LLC downgraded Udg Healthcare PLC to a hold rating and increased their price target for the company from GBX 760 ($10.03) to GBX 785 ($10.35) in a report on Wednesday, May 24th. Finally, Numis Securities Ltd reissued a hold rating and issued a GBX 730 ($9.63) price target on shares of Udg Healthcare PLC in a report on Tuesday, May 23rd. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus price target of GBX 799.43 ($10.55).

Shares of Udg Healthcare PLC (UDG) traded up 1.40% during midday trading on Thursday, hitting GBX 831.50. The stock had a trading volume of 471,316 shares. The company’s market cap is GBX 2.06 billion. Udg Healthcare PLC has a one year low of GBX 567.00 and a one year high of GBX 886.50. The stock has a 50 day moving average of GBX 847.66 and a 200-day moving average of GBX 751.72.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/04/udg-healthcare-plc-udg-given-add-rating-at-peel-hunt.html.

In other news, insider Chris Corbin sold 100,000 shares of the stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of GBX 813 ($10.72), for a total transaction of £813,000 ($1,072,417.89). Also, insider Jez Moulding purchased 18,000 shares of the company’s stock in a transaction dated Wednesday, May 31st. The shares were bought at an average price of GBX 808 ($10.66) per share, for a total transaction of £145,440 ($191,848.04).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.